by Colin Todhunter, Global Research:

Many scientists lobbying for the deregulation of agricultural biotechnology ‘new genomic techniques’ (NGTs) in the European Union have either direct or indirect interests in commercialising and marketing new genetically modified organisms (GMOs). They have patents or patent applications or other connections to the seed industry.  

That is the conclusion of a September 2022 investigatory report commissioned by the Greens/EFA in the European Parliament – Behind the smokescreen: Vested interests of EU scientists lobbying for GMO deregulation. These scientists will benefit financially or in terms of career development, either personally or through their organisations.